Tuesday, October 18th, 2011 7:00 am - 6:30 pm
Baltimore Convention Center
The business of drug discovery is changing. Over the last several years a new model has emerged bridging academic translational strengths with the pharmaceutical and biotechnology industries. What are the opportunities, challenges and risks to be addressed to forge these alliances? What are best practices? What could this new future look like?